Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis. Reumatismo [Internet]. 2017 Dec. 21 [cited 2025 Jun. 15];69(4):184-8. Available from: https://www.reumatismo.org/reuma/article/view/1013